These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21340661)

  • 41. Pharmacokinetic Interactions Between Mirabegron and Metformin, Warfarin, Digoxin or Combined Oral Contraceptives.
    Groen-Wijnberg M; van Dijk J; Krauwinkel W; Kerbusch V; Meijer J; Tretter R; Zhang W; van Gelderen M
    Eur J Drug Metab Pharmacokinet; 2017 Jun; 42(3):417-429. PubMed ID: 27350625
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cilomilast: pharmacokinetic and pharmacodynamic interactions with digoxin.
    Zussman BD; Kelly J; Murdoch RD; Clark DJ; Mbchb ; Schubert C; Collie H
    Clin Ther; 2001 Jun; 23(6):921-31. PubMed ID: 11440291
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A pharmacokinetic interaction study of ticagrelor and digoxin in healthy volunteers.
    Teng R; Butler K
    Eur J Clin Pharmacol; 2013 Oct; 69(10):1801-8. PubMed ID: 23748750
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Linagliptin (Trajenta): a selective DPP-4 inhibitor with limited renal elimination].
    Scheen AJ; Van Gaal LF
    Rev Med Liege; 2012 Feb; 67(2):91-7. PubMed ID: 22482239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacology, efficacy, and safety of linagliptin for the treatment of type 2 diabetes mellitus.
    Neumiller JJ
    Ann Pharmacother; 2012 Mar; 46(3):358-67. PubMed ID: 22318932
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro P-glycoprotein interactions and steady-state pharmacokinetic interactions between tolvaptan and digoxin in healthy subjects.
    Shoaf SE; Ohzone Y; Ninomiya S; Furukawa M; Bricmont P; Kashiyama E; Mallikaarjun S
    J Clin Pharmacol; 2011 May; 51(5):761-9. PubMed ID: 20679500
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Jentadueto, fixed combination of linagliptin plus metformin for the treatment of type 2 diabetes].
    Scheen AJ; Van Gaal LF
    Rev Med Liege; 2013 Sep; 68(9):479-85. PubMed ID: 24180204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A validated LC-MS/MS method for simultaneous determination of linagliptin and metformin in spiked human plasma coupled with solid phase extraction: Application to a pharmacokinetic study in healthy volunteers.
    Abbas Moussa B; Mahrouse MA; Fawzy MG
    J Pharm Biomed Anal; 2019 Jan; 163():153-161. PubMed ID: 30312887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. No effect of imidafenacin, a novel antimuscarinic drug, on digoxin pharmacokinetics in healthy subjects.
    Nakade S; Ohno T; Nakayama K; Kitagawa J; Hashimoto Y; Ohnishi A; Miyata Y
    Drug Metab Pharmacokinet; 2008; 23(2):95-100. PubMed ID: 18445988
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The concentration-dependent binding of linagliptin (BI 1356) and its implication on efficacy and safety.
    Wright S; Singh RP; Retlich S; Graefe-Mody U; Derendorf H
    Int J Clin Pharmacol Ther; 2012 May; 50(5):323-30. PubMed ID: 22541836
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Do therapeutic doses of acarbose alter the pharmacokinetics of digoxin?
    Cohen E; Almog S; Staruvin D; Garty M
    Isr Med Assoc J; 2002 Oct; 4(10):772-5. PubMed ID: 12389338
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Renal impairment has no clinically relevant effect on the long-term exposure of linagliptin in patients with type 2 diabetes.
    Friedrich C; Emser A; Woerle HJ; Graefe-Mody U
    Am J Ther; 2013; 20(6):618-21. PubMed ID: 23411609
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Linagliptin: a review of its use in the management of type 2 diabetes mellitus.
    Deeks ED
    Drugs; 2012 Sep; 72(13):1793-824. PubMed ID: 22913735
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of eslicarbazepine acetate on the pharmacokinetics of digoxin in healthy subjects.
    Vaz da Silva M; Costa R; Soares E; Maia J; Falcão A; Almeida L; Soares da Silva P
    Fundam Clin Pharmacol; 2009 Aug; 23(4):509-14. PubMed ID: 19500154
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of multiple doses of fimasartan, an angiotensin II receptor antagonist, on the steady-state pharmacokinetics of digoxin in healthy volunteers.
    Yi S; Kim JW; Kim TE; Kim J; Jun YK; Choi J; Yoon SH; Cho JY; Song SH; Shin SG; Jang IJ; Yu KS
    Int J Clin Pharmacol Ther; 2011 May; 49(5):321-7. PubMed ID: 21543035
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pharmacological and clinical profiles of the DPP-4 inhibitor linagliptin (Trazenta)].
    Ohmura T; Hayashi N; Encinas J
    Nihon Yakurigaku Zasshi; 2012 Apr; 139(4):174-83. PubMed ID: 22498683
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of saquinavir/ritonavir on P-glycoprotein activity in healthy volunteers using digoxin as a probe.
    Schmitt C; Kaeser B; Riek M; Bech N; Kreuzer C
    Int J Clin Pharmacol Ther; 2010 Mar; 48(3):192-9. PubMed ID: 20197013
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lack of mutual pharmacokinetic interaction between cerivastatin, a new HMG-CoA reductase inhibitor, and digoxin in healthy normocholesterolemic volunteers.
    Weber P; Lettieri JT; Kaiser L; Mazzu AL
    Clin Ther; 1999 Sep; 21(9):1563-75. PubMed ID: 10509851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of BI 1356, an inhibitor of dipeptidyl peptidase 4, in healthy male volunteers.
    Hüttner S; Graefe-Mody EU; Withopf B; Ring A; Dugi KA
    J Clin Pharmacol; 2008 Oct; 48(10):1171-8. PubMed ID: 18812608
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lack of a pharmacokinetic interaction between a new smoking cessation therapy, varenicline, and digoxin in adult smokers.
    Faessel HM; Burstein AH; Troutman MD; Willavize SA; Rohrbacher KD; Clark DJ
    Eur J Clin Pharmacol; 2008 Nov; 64(11):1101-9. PubMed ID: 18661125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.